Post by
Alex1726 on Oct 09, 2024 3:54pm
PMN penny stock again
It is already too late for that compound , there is plenty of them in developement and Mab doesn't have the regulator's favor because it is too costly and to complicated to manage. The problem with thoses crooks is they never intended to conduct any clinical trials they just wanted the prefect deal to fulfill their pockets, and that deal never came and now it is too late.
https://link.springer.com/article/10.1007/s40291-024-00738-6#Fig2
Comment by
Hafness on Oct 10, 2024 4:12pm
I guess it is safe to say that there will be no movement till first clinical read outs. That is pretty far off. Couple of years. How do they stay on Nasdaq being below 5$ this long. Can't keep doing splits dissolving current ownership. Right?
Comment by
G1945V on Oct 10, 2024 7:04pm
If I remember correctly, we were here once before with the Nasdaq issue. The insiders stepped in and pumped it back up to $2 — the rinse-and-repeat scenario. A good time to buy. jmo G1945V